Compare BridgeBio Pharma Inc (BBIO) vs VanEck Semiconductor ETF (SMH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs VanEck Semiconductor ETF — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.61B), while VanEck Semiconductor ETF trades at $582.75. Which is the better fit depends on your goals.
| BBIO | SMH | |
|---|---|---|
Market Cap | $16.61B | — |
Sector | Health | — |
52-Week High | $90.17 | $668.91 |
52-Week Low | $47.29 | $286.43 |
Enterprise Value | $18.16B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SMH trades at $582.70, up 1.96% today, with a bullish technical signal from moving averages but a neutral stance from oscillators. The ETF faces mixed sentiment, with some analysts downgrading to Hold amid competition from income-focused alternatives like CHPY, while others highlight potential from sustained AI spending. Key support lies near $575, with resistance at $588.
Outlook remains cautiously optimistic given AI-driven semiconductor demand, but risks include market volatility and concentrated holdings. Institutional activity shows mixed signals, with recent large purchases offset by sales. The ETF's performance hinges on broader tech sector trends and semiconductor cycle dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About VanEck Semiconductor ETF
The fund normally invests at least 80% of its total assets in securities that comprise the target index. The index includes common stocks and depositary receipts of US exchange-listed companies in the semiconductor industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a US exchange. The fund is non-diversified.
Read more on SMH →
